Cargando…
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
Breast cancer remains a leading cause of cancer-related death internationally. Treatment approaches for metastatic breast cancer have evolved in recent years; however chemotherapy remains a core component for the majority of patients. Agents such as anthracyclines and taxanes have been extensively s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294649/ https://www.ncbi.nlm.nih.gov/pubmed/25610001 http://dx.doi.org/10.2147/IJWH.S74462 |